FDA's Marty Makary sits down with CNBC's Annika Kim Constantino to discuss the vaccine regulatory environment, compounding GLP-1 drugs and his efforts to change a large swath of prescription drugs to over-the-counter. He's looking at drugs such as vaginal estrogen and nausea medications to be available without a prescription. ...